Login / Signup

Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.

Benjamin E PetersonRobert A HarringtonGregg W StonePhillippe Gabriel StegC Michael GibsonChristian W HammMatthew J PriceRenato Deláscio LopesSergio LeonardiJayne PratsEfthymios N DeliargyrisKenneth W MahaffeyHarvey D WhiteDeepak L Bhatt
Published in: Circulation. Cardiovascular interventions (2022)
gov; Unique identifier: NCT01156571, NCT00385138, NCT00305162.
Keyphrases
  • patients undergoing
  • coronary artery disease
  • coronary artery
  • adipose tissue
  • metabolic syndrome
  • weight loss
  • type diabetes
  • antiplatelet therapy
  • heart failure
  • obese patients
  • atrial fibrillation
  • aortic stenosis